Despite a major share price drop, Sailong Pharmaceutical's P...
Despite a major share price drop, Sailong Pharmaceutical's P/S remains high. Poor three-year revenue trends and a high P/S ratio suggest the current share price may not be sustainable.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000028848c9fe2d536.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment